Research Triangle Park, NC, March 30, 2010 – Quintiles’ Global Central Laboratory in China has won the national “Best Central Lab 2009” award from Shanghai Mental Health Center.
“This national award is a wonderful confirmation of all the hard work our Beijing staff have put into developing the right laboratory solutions to deliver clean, reliable and comparable data to our customers,” said Alan Ong, Vice President and General Manager, Global Central Labs, Asia. “The Central Lab organization is a key component of Quintiles’ comprehensive services that help our customers navigate risk in the changing biopharmaceutical environment. We have the scientific expertise, technical capability and local knowledge to reduce complexity and get new drugs to market sooner. I must thank Shanghai Mental Health Center for this award as we look forward to building deeper alliances with customers in the years ahead.”
The award was presented by Professor Fanghua Li, Director of the Clinical Research Center at Shanghai Mental Health Center. Wang You, Project Manager for Quintiles Central Laboratory in China, accepted the award on behalf of Quintiles at an award ceremony in Shanghai.
Quintiles Global Central Laboratories is a leader in developing novel biomarker assays to support clinical development of targeted therapies and other personalized medicine advances. Today, at labs in China, Scotland and the United States, Quintiles can perform Immunohistochemistry (IHC) and Fluorescence In Situ Hybridization (FISH) testing. Quintiles’ biomarker tests are used to target genes that affect cancer cell growth and mutation.
Quintiles Central Laboratories’ recently opened a new facility in Japan to join the world’s largest global network of sites certified by the College of American Pathologists, with wholly owned facilities in the U.S., Europe, South Africa, India, China and Singapore, and a tightly controlled network of affiliate laboratories in Argentina and Brazil. The network recently expanded its anatomical pathology capability in China.
Quintiles is the only fully integrated biopharmaceutical services company offering clinical, commercial, consulting and capital solutions worldwide. The Quintiles network of more than 20,000 engaged professionals in 60 countries works with an unwavering commitment to patients, safety and ethics. Quintiles helps biopharmaceutical companies navigate risk and seize opportunities in an environment where change is constant. For more information, please visit www.quintiles.com.